Virax Biolabs Group Stock Alpha and Beta Analysis
| VRAX Stock | USD 2.01 0.07 3.61% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Virax Biolabs Group. It also helps investors analyze the systematic and unsystematic risks associated with investing in Virax Biolabs over a specified time horizon. Remember, high Virax Biolabs' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Virax Biolabs' market risk premium analysis include:
Beta (0.38) | Alpha (1.00) | Risk 9.21 | Sharpe Ratio (0.11) | Expected Return (1.01) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Virax |
Virax Biolabs Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Virax Biolabs market risk premium is the additional return an investor will receive from holding Virax Biolabs long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Virax Biolabs. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Virax Biolabs' performance over market.| α | -1 | β | -0.38 |
Virax Biolabs expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Virax Biolabs' Buy-and-hold return. Our buy-and-hold chart shows how Virax Biolabs performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Virax Biolabs Market Price Analysis
Market price analysis indicators help investors to evaluate how Virax Biolabs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Virax Biolabs shares will generate the highest return on investment. By understating and applying Virax Biolabs stock market price indicators, traders can identify Virax Biolabs position entry and exit signals to maximize returns.
Virax Biolabs Return and Market Media
The median price of Virax Biolabs for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 2.04 with a coefficient of variation of 41.24. The daily time series for the period is distributed with a sample standard deviation of 1.04, arithmetic mean of 2.52, and mean deviation of 0.78. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox Virus Real-Time PCR Detection Kits with Cosmos Health Inc. | 09/16/2024 |
2 | Virax Biolabs Plans New Share Offering - TipRanks | 09/30/2024 |
3 | Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland | 10/23/2024 |
4 | Virax Biolabs Sees Asset Growth Amid Financial Loss - TipRanks | 11/20/2024 |
About Virax Biolabs Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Virax or other stocks. Alpha measures the amount that position in Virax Biolabs Group has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2023 | 2024 (projected) | Payables Turnover | 0.0621 | 2.32 | 2.44 | Days Of Inventory On Hand | 886.02 | 208.26 | 307.2 |
Virax Biolabs Upcoming Company Events
As portrayed in its financial statements, the presentation of Virax Biolabs' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Virax Biolabs' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Virax Biolabs' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Virax Biolabs. Please utilize our Beneish M Score to check the likelihood of Virax Biolabs' management manipulating its earnings.
| 27th of September 2023 Upcoming Quarterly Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 12th of June 2024 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Virax Biolabs
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Virax Stock Analysis
When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.